TrialClinical and experimental immunology2016

Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupus erythematosus.

K Masek-Hammerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.